Financing
Thermo Fisher Scientific·Cash Flow Statement·7 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Proceeds from issuance of debt | — | — | — | $2.8B | — | — | $4.9B | $5.2B |
| Repurchases of common stock | — | — | $1B | $2B | $0 | $963M | $37M | $3B |
| Repayments of debt | $0 | $1.1B | $2.5B | $838M | $787M | $0 | $787M | $1.4B |
| Net cash from financing activities | -$115M | -$1.2B | -$3.7B | -$102M | -$991M | -$632M | $3.5B | $1.1B |
| Proceeds from Issuance of Commercial Paper | $0 | $0 | $0 | $0 | — | — | — | $389M |
| Dividends paid | $149M | $150M | $149M | $149M | $162M | $163M | $162M | $162M |
| Other, net | $35M | $67M | $0 | $45M | — | -$4M | $91M | $39M |